![2024 FDA Draft Guidance on Diversity Action Plans Enhancing Inclusion in Clinical Studies](https://www.integrait.co/wp-content/uploads/2024/07/2024-FDA-Draft-Guidance-on-Diversity-Action-Plans-Enhancing-Inclusion-in-Clinical-Studies.jpg)
2024 FDA Draft Guidance on Diversity Action Plans: Enhancing Inclusion in Clinical Studies
On June 26, 2024, the FDA issued new draft guidance describing the format and content, medical products, clinical studies, timing, and process for submitting diversity